HRP20130225T1 - Formulacija s odgođenim otpuštanjem koja sadrži 3-(2-dimetilaminometilcikloheksil) fenol - Google Patents
Formulacija s odgođenim otpuštanjem koja sadrži 3-(2-dimetilaminometilcikloheksil) fenol Download PDFInfo
- Publication number
- HRP20130225T1 HRP20130225T1 HRP20130225TT HRP20130225T HRP20130225T1 HR P20130225 T1 HRP20130225 T1 HR P20130225T1 HR P20130225T T HRP20130225T T HR P20130225TT HR P20130225 T HRP20130225 T HR P20130225T HR P20130225 T1 HRP20130225 T1 HR P20130225T1
- Authority
- HR
- Croatia
- Prior art keywords
- weight
- hours
- dosage form
- active ingredient
- phenol
- Prior art date
Links
- JIRYWFYYBBRJAN-UHFFFAOYSA-N 3-[2-[(dimethylamino)methyl]cyclohexyl]phenol Chemical compound CN(C)CC1CCCCC1C1=CC=CC(O)=C1 JIRYWFYYBBRJAN-UHFFFAOYSA-N 0.000 title claims 2
- 239000002552 dosage form Substances 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 5
- 239000011159 matrix material Substances 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 229920002678 cellulose Polymers 0.000 claims 2
- 229920003086 cellulose ether Polymers 0.000 claims 2
- CYELFIHNCBWBIU-UHFFFAOYSA-N 3-[2-(dimethylamino)-1-methylcyclohexyl]phenol Chemical compound CN(C)C1CCCCC1(C)C1=CC=CC(O)=C1 CYELFIHNCBWBIU-UHFFFAOYSA-N 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- JIRYWFYYBBRJAN-ZFWWWQNUSA-N faxeladol Chemical group CN(C)C[C@@H]1CCCC[C@H]1C1=CC=CC(O)=C1 JIRYWFYYBBRJAN-ZFWWWQNUSA-N 0.000 claims 1
- -1 hydroxycellulose Polymers 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pretreatment Of Seeds And Plants (AREA)
Claims (5)
1. Oblik doziranja za kontrolirano oslobađanje aktivnog sastojka 3-(2-dimetilamino-metilcikloheksil)fenola ili jedne od njegovih farmaceutski prihvatljivih soli, koji
- in vitro, mjereno u skladu sa Europskom farmakopejom sa miješalicom sa lopaticom u puferu kod pH vrijednosti od 6.8, te temperature od 37°C i 75 okr/min, otpušta
- nakon 0.5 sata od 9.0 do 31 % težinski,
- nakon 1 sata od 20 do 48% težinski,
- nakon 2 sata od 31 do 65% težinski,
- nakon 3 sata od 42 do 76% težinski,
- nakon 4 sata od 50 do 83% težinski,
- nakon 6 sati od 60 do 94% težinski,
- nakon 8 sati od 71 do 99% težinski,
- nakon 12 sati više od 79% težinski
aktivnog sastojka koji je izvorno sadržan u obliku doziranja,
- sadrži polimerni matriks koji se temelji na celuloznom eteru ili celuloznom esteru koji kod koncentracije od 2.0% težinski u vodenoj otopini kao 20°C ima viskoznost u rasponu od 3 000 do 150 000 mPa·s,
pri čemu je barem dio aktivnog sastojka sadržan u polimernom matriksu,
pri čemu težinski udio polimernog matriksa iznosi od 5 do 85% težinski, u odnosu na ukupnu težinu oblika doziranja, te
pri čemu je celulozni eter ili celulozni ester odabran iz skupine koja se sastoji od metilceluloze, etilceluloze, hidroksiceluloze, hidroksipropilceluloze, karboksimetilceluloze i hidroksipropilmetilceluloze.
2. Oblik doziranja prema zahtjevu 1, naznačena time da je aktivni sastojak (1R,2R)-3-(2-dimetilaminometilcikcloheksil)fenol ili jedna od njegovih farmaceutski prihvatljivih soli.
3. Oblik doziranja prema zahtjevu 1 ili 2, naznačen time da je predviđen u obliku tablete.
4. Uporaba aktivnog sastojka 3-(2-dimetilaminometilcikcloheksil)fenola ili jedne od njegovih farmaceutski prihvatljivih soli naznačena time da je za proizvodnju oblika doziranja prema jednom od zahtjeva 1 do 3 za suzbijanje boli.
5. Uporaba prema zahtjevu 4, naznačena time da se davanje odvija oralnim putem.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005044212 | 2005-09-15 | ||
| PCT/EP2006/008988 WO2007031326A2 (de) | 2005-09-15 | 2006-09-15 | Retardformulierung von 3-(2-dimethylaminomethyl-cyclohexyl)-phenol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20130225T1 true HRP20130225T1 (hr) | 2013-04-30 |
Family
ID=37744782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20130225TT HRP20130225T1 (hr) | 2005-09-15 | 2013-03-15 | Formulacija s odgođenim otpuštanjem koja sadrži 3-(2-dimetilaminometilcikloheksil) fenol |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20090104266A1 (hr) |
| EP (1) | EP1928441B1 (hr) |
| JP (1) | JP2009507875A (hr) |
| KR (1) | KR20080059212A (hr) |
| CN (1) | CN101262857A (hr) |
| AU (1) | AU2006291422B2 (hr) |
| BR (1) | BRPI0621466A2 (hr) |
| CA (1) | CA2621270A1 (hr) |
| CY (1) | CY1113943T1 (hr) |
| DK (1) | DK1928441T3 (hr) |
| EC (1) | ECSP088285A (hr) |
| ES (1) | ES2402206T3 (hr) |
| HR (1) | HRP20130225T1 (hr) |
| IL (1) | IL189820A0 (hr) |
| NO (1) | NO20081785L (hr) |
| NZ (1) | NZ566473A (hr) |
| PL (1) | PL1928441T3 (hr) |
| PT (1) | PT1928441E (hr) |
| RU (1) | RU2445081C2 (hr) |
| SI (1) | SI1928441T1 (hr) |
| WO (1) | WO2007031326A2 (hr) |
| ZA (1) | ZA200802269B (hr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10356362A1 (de) | 2003-11-28 | 2005-06-23 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen |
| EP2085081A1 (de) * | 2008-02-04 | 2009-08-05 | Grünenthal GmbH | 3-(2-Dimethylaminomethyl-cyclohexyl)-phenol gegen polyneuropathischen Schmerz |
| MX2018006903A (es) * | 2015-12-08 | 2018-11-09 | Ardea Biosciences Inc | Composicion farmaceutica. |
| WO2019156074A1 (ja) | 2018-02-06 | 2019-08-15 | 第一三共株式会社 | アミノアルキル化合物 |
| CN112566668A (zh) * | 2018-06-22 | 2021-03-26 | 快力胶囊股份有限公司 | 肠溶性硬胶囊 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4329794C2 (de) * | 1993-09-03 | 1997-09-18 | Gruenenthal Gmbh | Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung |
| DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| DE19525137C2 (de) * | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
| DE10059411A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Verwendung von 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz |
| DE10109763A1 (de) * | 2001-02-28 | 2002-09-05 | Gruenenthal Gmbh | Pharmazeutische Salze |
| US20050176790A1 (en) * | 2001-02-28 | 2005-08-11 | Johannes Bartholomaus | Pharmaceutical salts |
| JP4207651B2 (ja) * | 2003-05-07 | 2009-01-14 | ソニー株式会社 | 充電器 |
| DE10333835A1 (de) * | 2003-07-24 | 2005-03-10 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung |
-
2005
- 2005-09-15 US US12/066,927 patent/US20090104266A1/en not_active Abandoned
-
2006
- 2006-09-15 PT PT68057298T patent/PT1928441E/pt unknown
- 2006-09-15 AU AU2006291422A patent/AU2006291422B2/en not_active Ceased
- 2006-09-15 SI SI200631539T patent/SI1928441T1/sl unknown
- 2006-09-15 CA CA002621270A patent/CA2621270A1/en not_active Abandoned
- 2006-09-15 JP JP2008530423A patent/JP2009507875A/ja active Pending
- 2006-09-15 ES ES06805729T patent/ES2402206T3/es active Active
- 2006-09-15 BR BRPI0621466-5A patent/BRPI0621466A2/pt not_active IP Right Cessation
- 2006-09-15 NZ NZ566473A patent/NZ566473A/en not_active IP Right Cessation
- 2006-09-15 PL PL06805729T patent/PL1928441T3/pl unknown
- 2006-09-15 KR KR1020087009033A patent/KR20080059212A/ko active IP Right Grant
- 2006-09-15 WO PCT/EP2006/008988 patent/WO2007031326A2/de active Application Filing
- 2006-09-15 CN CNA2006800338007A patent/CN101262857A/zh active Pending
- 2006-09-15 EP EP06805729A patent/EP1928441B1/de active Active
- 2006-09-15 RU RU2008114051/15A patent/RU2445081C2/ru not_active IP Right Cessation
- 2006-09-15 DK DK06805729.8T patent/DK1928441T3/da active
-
2008
- 2008-02-28 IL IL189820A patent/IL189820A0/en unknown
- 2008-03-10 ZA ZA200802269A patent/ZA200802269B/xx unknown
- 2008-03-14 EC EC2008008285A patent/ECSP088285A/es unknown
- 2008-04-11 NO NO20081785A patent/NO20081785L/no not_active Application Discontinuation
-
2011
- 2011-10-26 US US13/282,005 patent/US20120039963A1/en not_active Abandoned
-
2013
- 2013-03-15 HR HRP20130225TT patent/HRP20130225T1/hr unknown
- 2013-04-23 CY CY20131100328T patent/CY1113943T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1928441T1 (sl) | 2013-04-30 |
| WO2007031326A3 (de) | 2007-06-07 |
| US20120039963A1 (en) | 2012-02-16 |
| ES2402206T3 (es) | 2013-04-29 |
| DK1928441T3 (da) | 2013-04-08 |
| ECSP088285A (es) | 2008-04-28 |
| AU2006291422B2 (en) | 2012-07-05 |
| RU2445081C2 (ru) | 2012-03-20 |
| WO2007031326A2 (de) | 2007-03-22 |
| EP1928441B1 (de) | 2013-02-27 |
| CA2621270A1 (en) | 2007-03-22 |
| CN101262857A (zh) | 2008-09-10 |
| NZ566473A (en) | 2011-05-27 |
| US20090104266A1 (en) | 2009-04-23 |
| CY1113943T1 (el) | 2016-07-27 |
| NO20081785L (no) | 2008-06-02 |
| PT1928441E (pt) | 2013-03-18 |
| PL1928441T3 (pl) | 2013-05-31 |
| JP2009507875A (ja) | 2009-02-26 |
| RU2008114051A (ru) | 2010-01-20 |
| KR20080059212A (ko) | 2008-06-26 |
| ZA200802269B (en) | 2008-12-31 |
| EP1928441A2 (de) | 2008-06-11 |
| IL189820A0 (en) | 2008-11-03 |
| AU2006291422A1 (en) | 2007-03-22 |
| BRPI0621466A2 (pt) | 2012-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20130225T1 (hr) | Formulacija s odgođenim otpuštanjem koja sadrži 3-(2-dimetilaminometilcikloheksil) fenol | |
| RU2485942C2 (ru) | Бупропиона гидробромид и его терапевтические применения | |
| CN103391767B (zh) | 治疗心血管疾病的组合物和方法 | |
| AU2014363599B2 (en) | Orally disintegrating solid dosage unit containing an estetrol component | |
| BR112020024269A2 (pt) | combinação farmacêutica, composição e formulação de combinação contendo ativador de glucoquinase e ativador de receptor ppar e métodos de preparação e usos dos mesmos | |
| ES2587333T3 (es) | Un método para aliviar los signos y síntomas de la espasticidad | |
| PH12015502134A1 (en) | Mosapride sustained-release preparation for providing pharmacological and clinical effects with once-a-day administration | |
| EA200900087A1 (ru) | Применение гидрофильной матрицы, содержащей производное полиакриловой кислоты, простой эфир целлюлозы и дезинтегрирующий агент, в производстве медикаментов для лечения заболеваний женских гениталий | |
| NO20090141L (no) | Stabiliserte, farmasøytiske preparater som omfatter fesoterodin | |
| WO2008107149A3 (de) | Darreichungsform mit erschwertem missbrauch | |
| HRP20110697T1 (hr) | Uporaba flibanserina za liječenje poremećaja seksualne želje u pre-menopauzi | |
| RU2011129205A (ru) | Быстро распадающиеся таблетки, содержащие капецитабан | |
| HRP20171739T1 (hr) | Postupci i kompozicije za liječenje simptoma povezanih s posttraumatskim stresnim poremećajem korištenjem ciklobenzaprina | |
| AR069875A1 (es) | Composiciones de temazepam para tabletas de desintegracion oral y metodo de preparacion | |
| SG10201407947WA (en) | Compressible-coated pharmaceutical compositions and tablets and methods of manufacture | |
| BRPI0922796A2 (pt) | Comprimido farmacêutico para administração por via oral e método de fabricação do mesmo | |
| JP2015511635A5 (hr) | ||
| EP2799428A3 (en) | Glucagon antagonists | |
| US20220347157A1 (en) | Sustained release pharmaceutical compositions comprising (1r, 5s)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane | |
| JP2019089796A5 (hr) | ||
| JP2007529564A5 (hr) | ||
| AR063138A1 (es) | Comprimidos pediatricos de capecitabina | |
| JP2016108327A5 (hr) | ||
| UA112352C2 (uk) | Фармацевтична композиція для профілактики і лікування психічних, поведінкових, когнітивних розладів | |
| RU2006137329A (ru) | Распадающиеся таблетки, содержащие ликарбазепин |